Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways
Jing Huang,
No information about this author
Lei Li,
No information about this author
Liyan Xu
No information about this author
et al.
Marine Drugs,
Journal Year:
2025,
Volume and Issue:
23(1), P. 47 - 47
Published: Jan. 19, 2025
Inflammatory
bowel
disease
(IBD)
is
characterized
by
uncontrolled,
chronic
relapsing
inflammation
in
the
gastrointestinal
tract
and
has
become
a
global
healthcare
problem.
Here,
we
aimed
to
illustrate
anti-inflammatory
activity
underlying
mechanism
of
methyl
3-bromo-4,5-dihydroxybenzoate
(MBD),
compound
derived
from
marine
organisms,
especially
IBD,
using
zebrafish
model.
The
results
indicated
that
MBD
could
inhibit
inflammatory
responses
induced
CuSO4,
tail
amputation
LPS
zebrafish.
Furthermore,
notably
inhibited
intestinal
migration
immune
cells,
enhanced
integrity
gut
mucosal
barrier
improved
peristalsis
function
IBD
model
trinitro-benzene-sulfonic
acid
(TNBS).
In
addition,
ROS
elevation
TNBS.
Network
pharmacology
analysis,
molecular
docking,
transcriptomics
sequencing
RT-PCR
were
conducted
investigate
potential
mechanism.
showed
regulate
TLR/NF-κB
pathways
inhibiting
mRNA
expression
TNF-α,
NF-κB,
IL-1,
IL-1β,
IL6,
AP1,
IFNγ,
IKKβ,
MyD88,
STAT3,
TRAF1,
TRAF6,
NLRP3,
NOD2,
TLR3
TLR4,
promoting
IL4,
IκBα
Bcl-2.
conclusion,
these
findings
indicate
be
candidate
for
treatment
IBD.
Language: Английский
IHNV induced miR-19-3p modulates intestinal immune response of rainbow trout (Oncorhynchus mykiss) by targeting DHX58-dependent RLR signaling pathway in vitro and in vivo
Fish & Shellfish Immunology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 110200 - 110200
Published: Feb. 1, 2025
Language: Английский
A novel synthetic oxazolidinone derivative BS-153 attenuated LPS-induced inflammation via inhibiting NF-κB/pkcθ signaling pathway
Liyan Xu,
No information about this author
Jing Huang,
No information about this author
Rongchun Wang
No information about this author
et al.
Fish & Shellfish Immunology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 110292 - 110292
Published: March 1, 2025
Language: Английский
Recent Advances of the Zebrafish Model in the Discovery of Marine Bioactive Molecules
Changyu Liu,
No information about this author
Jiaxun Li,
No information about this author
Dexu Wang
No information about this author
et al.
Marine Drugs,
Journal Year:
2024,
Volume and Issue:
22(12), P. 540 - 540
Published: Nov. 30, 2024
Marine
natural
products
are
increasingly
utilized
in
nutrition,
cosmetics,
and
medicine,
garnering
significant
attention
from
researchers
globally.
With
the
expansion
of
marine
resource
exploration
recent
years,
demand
for
has
risen,
necessitating
rapid
cost-effective
activity
evaluations
using
model
organisms.
Zebrafish,
a
valuable
vertebrate
model,
become
an
efficient
tool
screening
identifying
safe,
active
molecules
products.
This
review,
based
on
nearly
10
years
literature,
summarizes
current
status
progress
zebrafish
models
evaluating
product
bioactivity.
It
also
highlights
their
potential
exploring
resources
with
health
benefits,
offering
reference
future
development
utilization
biological
resources.
Language: Английский